The global liquid biopsy market size is estimated to be worth $ 5.4 billion in 2023 and is expected to grow at compounded annual growth rate (CAGR) of 15.2%, during the forecast period. The growth in the liquid biopsy market size over the next decade is likely to be driven by the rise in demand for non invasive liquid biopsy products due to growing focus on early cancer detection.